Literature DB >> 21671176

Targeted silencing of heparanase gene by small interfering RNA inhibits invasiveness and metastasis of osteosarcoma cells.

Lei Fan1, Qiang Wu1, Xiaojuan Xing2, Yudong Liu1, Zengwu Shao3.   

Abstract

The effects of targeted silencing of heparanase gene by small interfering RNA (siRNA) on invasiveness and metastasis of osteosarcoma cells (MG63 cells) were investigated in the present study. Two complementary oligonucleotide strands were synthesized and inserted into pGenesil-1 vector based on the mRNA sequence of heparanase gene. The expression vector containing short hairpin RNA (pGenesil-shRNA) was constructed successfully. MG63 cells were randomly allocated into 3 groups: blank group, empty vector (pGenesil) transfected group and expression vector (pGenesil-shRNA) transfected group. Under the induction of Lipofectamine 2000, the recombinants were transfected into MG63 cells. Heparanase gene expression level was detected by RT-PCR and Western blotting. Cell proliferation was measured by MTT assay. Cell invasiveness and metastasis were examined by cell adhesion and Transwell-ECM assays. HUVECs migration assay was applied for the detection of angiogenesis. As compared with negative controls, the mRNA and protein expression levels of heparanase were down-regulated by 76.1% (P<0.01) and 75.3% (P<0.01) respectively in the pGenesil-shRNA transfected group. Meanwhile, the proliferation, adhesiveness, invasiveness and angiogenesis properties of MG63 cells were all significantly inhibited. It was suggested that targeted silencing of heparanase gene by siRNA could dramatically inhibit the invasiveness and metastasis of osteosarcoma cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671176     DOI: 10.1007/s11596-011-0379-2

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  22 in total

Review 1.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

Authors:  I Vlodavsky; Y Friedmann
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Heparin immobilized gold nanoparticles for targeted detection and apoptotic death of metastatic cancer cells.

Authors:  Kyuri Lee; Hyukjin Lee; Ki Hyun Bae; Tae Gwan Park
Journal:  Biomaterials       Date:  2010-09       Impact factor: 12.479

Review 3.  The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art.

Authors:  Irina Arnaoutova; Jay George; Hynda K Kleinman; Gabriel Benton
Journal:  Angiogenesis       Date:  2009-04-28       Impact factor: 9.596

4.  Antisense-mediated suppression of Heparanase gene inhibits melanoma cell invasion.

Authors:  Madhuchhanda Roy; Jane Reiland; Brian P Murry; Vladimir Chouljenko; Konstantin G Kousoulas; Dario Marchetti
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

5.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

6.  Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.

Authors:  Huajun Zhao; Haiying Liu; Yi Chen; Xianliang Xin; Jing Li; Yongtai Hou; Zhonghua Zhang; Xiongwen Zhang; Chengying Xie; Meiyu Geng; Jian Ding
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

7.  Heparanase expression correlates with angiogenesis and lymphangiogenesis in human lung cancer.

Authors:  Qingfu Zhang; Jian Ming; Yang Li; Siyang Zhang; Bo Li; Xueshan Qiu; Enhua Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2009-08-20

Review 8.  Heparanase: one molecule with multiple functions in cancer progression.

Authors:  Israel Vlodavsky; Michael Elkin; Ghada Abboud-Jarrous; Flonia Levi-Adam; Liat Fuks; Itay Shafat; Neta Ilan
Journal:  Connect Tissue Res       Date:  2008       Impact factor: 3.417

9.  Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis.

Authors:  Madhuchhanda Roy; Dario Marchetti
Journal:  J Cell Biochem       Date:  2009-02-01       Impact factor: 4.429

Review 10.  Heparanase: a target for drug discovery in cancer and inflammation.

Authors:  E A McKenzie
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

View more
  4 in total

Review 1.  Soluble syndecans: biomarkers for diseases and therapeutic options.

Authors:  Jessica Bertrand; Miriam Bollmann
Journal:  Br J Pharmacol       Date:  2018-07-23       Impact factor: 8.739

Review 2.  Syndecans in chronic inflammatory and autoimmune diseases: Pathological insights and therapeutic opportunities.

Authors:  Solomon A Agere; Eugene Y Kim; Nahid Akhtar; Salahuddin Ahmed
Journal:  J Cell Physiol       Date:  2018-03-25       Impact factor: 6.384

3.  Bioinformatics analysis of differentially expressed pathways related to the metastatic characteristics of osteosarcoma.

Authors:  Wei Sun; Xiaojun Ma; Jiakang Shen; Fei Yin; Chongren Wang; Zhengdong Cai
Journal:  Int J Mol Med       Date:  2016-06-27       Impact factor: 4.101

Review 4.  The role of extracelluar matrix in osteosarcoma progression and metastasis.

Authors:  Juncheng Cui; Dylan Dean; Francis J Hornicek; Zhiwei Chen; Zhenfeng Duan
Journal:  J Exp Clin Cancer Res       Date:  2020-09-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.